The advertisement promotes VYVGART Hytrulo as a novel treatment for adult patients with CIDP, highlighting important safety information and contraindications.
Creative Information
| CID: | 9ada7471-0284-4286-a7f6-d78afcb6835e |
| CRID: | 82_5970-1001442 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $20.00 |
| Timestamp: | 2/2/2026, 3:09:14 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 2/2/2026, 3:09:45 AM | 4.57s | |
| adomain_analysis | success | 2/2/2026, 3:09:44 AM | 2.57s | |
| adomain_capture | success | 2/2/2026, 3:09:41 AM | 0.25s | |
| ad_render | success | 2/2/2026, 3:09:40 AM | 25.02s | |
| brand_mapping | success | 2/2/2026, 3:09:14 AM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1094.06 KB | ||||||||||||||||||||||
| Render Time: | 9.71 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1223.37 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
